Progress on ocular siRNA gene-silencing therapy and drug delivery systems

被引：36

作者：

Jiang, Jinjin ^{[1
,2
]}

Zhang, Xinru ^{[1
,2
]}

Tang, Yue ^{[1
,2
]}

Li, Shuhan ^{[2
]}

Chen, Jing ^{[2
]}

机构：

[1] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, 1 DongQing Rd, Guiyang 550014, Peoples R China

[2] China Pharmaceut Univ, Dept Pharm, 639 Longmian Ave, Nanjing 211198, Peoples R China

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2021年 / 35卷 / 01期

关键词：

age-related macular degeneration; glaucoma; RNA interference technology; siRNA drugs; non-viral vectors; ENDOTHELIAL GROWTH-FACTOR; BETA-ADRENERGIC RECEPTORS; VEGF SIRNA; POSTERIOR SEGMENT; POLYETHYLENIMINE NANOPARTICLES; INTRAVITREAL INJECTION; MACULAR DEGENERATION; NONVIRAL VECTORS; RNA INTERFERENCE; CLINICAL-TRIAL;

D O I：

10.1111/fcp.12561

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Age-related macular degeneration (AMD) and glaucoma are global ocular diseases with high blindness rate. RNA interference (RNAi) is being increasingly used in the treatment of these disorders with siRNA drugs, bevasiranib, AGN211745 and PF-04523655 for AMD, and SYL040012 and QPI-1007 for glaucoma. Administration routes and vectors of gene drugs affect their therapeutic effect. Compared with the non-viral vectors, viral vectors have limited payload capacity and potential immunogenicity. This review summarizes the progress of the ocular siRNA gene-silencing therapy by focusing on siRNA drugs for AMD and glaucoma already used in clinical research, the main routes of drug delivery and the non-viral vectors for siRNA drugs.

引用

页码：4 / 24

页数：21

共 50 条

[41] Molecular engineering of dendrimer nanovectors for siRNA delivery and gene silencing
Cao, Yu
Liu, Xiaoxuan
Peng, Ling
FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING, 2017, 11 (04) : 663 - 675
[42] Molecular engineering of dendrimer nanovectors for siRNA delivery and gene silencing
Yu Cao
Xiaoxuan Liu
Ling Peng
Frontiers of Chemical Science and Engineering, 2017, 11 : 663 - 675
[43] Silencing the Catalase Gene with SiRNA for Enhanced Chemodynamic Therapy
Liu, Ying
Wang, Xin
Chen, Hanjun
Wu, Tingting
Cao, Yu
Liu, Zhihong
ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (07) : 8937 - 8945
[44] PAMAM dendrimers for efficient siRNA delivery and potent gene silencing
Zhou, Jiehua
Wu, Jiangyu
Hafdi, Nadia
Behr, Jean-Paul
Erbacher, Patrick
Peng, Ling
CHEMICAL COMMUNICATIONS, 2006, (22) : 2362 - 2364
[45] siRNA Delivery Using Nanocarriers - An Efficient Tool for Gene Silencing
Khurana, Bharat
Goyal, Amit K.
Budhiraja, Abhishek
Arora, Daisy
Vyas, Suresh P.
CURRENT GENE THERAPY, 2010, 10 (02) : 139 - 155
[46] A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications
Abosalha, Ahmed Khaled
Ahmad, Waqar
Boyajian, Jacqueline
Islam, Paromita
Ghebretatios, Merry
Schaly, Sabrina
Thareja, Rahul
Arora, Karan
Prakash, Satya
EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (02) : 149 - 161
[47] Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity
Akhtar, Saghir
Benter, Ibrahim
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) : 164 - 182
[48] Progress in psoriasis therapy via novel drug delivery systems
Vincent, Nitha
Devi, Ramya D.
Hari, Vedha B. N.
DERMATOLOGY REPORTS, 2014, 6 (01) : 14 - 18
[49] A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy
Liu, Xiaoxuan (xiaoxuanliucpu@163.com), 1600, American Chemical Society (140):
[50] A Dual Targeting Dendrimer-Mediated siRNA Delivery System for Effective Gene Silencing in Cancer Therapy
Dong, Yiwen
Yu, Tianzhu
Ding, Ling
Laurini, Erik
Huang, Yuanyu
Zhang, Mengjie
Weng, Yuhua
Lin, Shuting
Chen, Peng
Marson, Domenico
Jiang, Yifan
Giorgio, Suzanne
Pricl, Sabrina
Liu, Xiaoxuan
Rocchi, Palma
Peng, Ling
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (47) : 16264 - 16274

← 1 2 3 4 5 →